NL-OMON42611已完成不适用
Translational trial to explore the pharmacodynamic effects of multiple oral dose administrations of tapentadol PR, pregabalin, and combinations of both in an intradermal capsaicin hypersensitization model in healthy subjects. - Pharmacodynamic study with tapentadol PR and pregabalin
Grunenthal0 个研究点目标入组 84 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male subjects
- •- 18-55 yrs, inclusive
- •- BMI: 20.0-30.0 kg/m2, inclusive
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood (for men) / 1.0 liters of blood (for women) in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
Clinical Pharmacological Study to Investigate the Effects of Mucosta Ophthalmic Suspension UD2% on Ocular Surface Cells in Patients with Dry EyeDry eyeJPRN-UMIN000022629Otsuka Pharmaceutical Co., Ltd.15
进行中（未招募）
不适用
Clinical trial to assess the pharmacokinetic/Pharmacodynamic characteristics and safety/tolerability of CKD-519 new formulation in healthy male subjectsEndocrine, nutritional and metabolic diseaseKCT0001729Chong Kun Dang30
招募中
1 期
MYCATJapanese Patients with Pulmonary MABC DiseaseJPRN-jRCT2031220211Ho Namkoong10
尚未招募
Unknown
Study comparing anti-tuberculosis drug levels in saliva, plasma, and urine in patientsTuberculosisACTRN12623001088639Western Sydney Local Health District30
进行中（未招募）
不适用
A Trial Investigating the Pharmacokinetic Properties of NN1250 in Children, Adolescents and Adults with Type 1 DiabetesType I diabetes mellitusMedDRA version: 12.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusEUCTR2008-008306-43-DEovo Nordisk A/S